Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06889766
What this trial is testing

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

Who this might be right for
Advanced MelanomaMelanoma MetastaticSarcoma
Centre Hospitalier Universitaire Vaudois 9
Testing effectiveness (Phase 2)UnknownNCT02625337
What this trial is testing

Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients

Who this might be right for
Metastatic Melanoma
The Netherlands Cancer Institute 32
Very early researchStudy completedNCT02316795
What this trial is testing

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

Who this might be right for
Breast CancerCancer of BreastCancer of the Breast+2 more
Washington University School of Medicine 20
Not applicableStudy completedNCT03419637
What this trial is testing

Mobile Devices as Educational Skin History Tools

Who this might be right for
Skin Cancer
University of Pennsylvania 70
Not applicableLooking for participantsNCT07148245
What this trial is testing

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Who this might be right for
Cutaneous MelanomaCutaneous Melanoma, Stage IIICutaneous Melanoma by AJCC V7 Stage+1 more
University of California, San Francisco 300
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Not applicableNot Yet RecruitingNCT06870994
What this trial is testing

Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma

Who this might be right for
Cutaneous Metastatic Melanoma
Sona Nanotech Inc 10
Not applicableStudy completedNCT03225365
What this trial is testing

Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Hospices Civils de Lyon 5
Not applicableStudy completedNCT06291753
What this trial is testing

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

Who this might be right for
Primary Malignant Melanoma of the Esophagus
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00070642
What this trial is testing

CPG 7909 Injection in Melanoma

Who this might be right for
Carcinoma, Melanoma
Pfizer 184
Not applicableLooking for participantsNCT06976073
What this trial is testing

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

Who this might be right for
Diabetes Mellitus, Type 2Diabetic FootPeripheral Arterial Disease+2 more
HJN Sverige AB/Neko Health 8,000
Not applicableStudy completedNCT05615883
What this trial is testing

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

Who this might be right for
Melanoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 16
Not applicableEnded earlyNCT03630601
What this trial is testing

Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers

Who this might be right for
Breast CarcinomaHealthy SubjectMalignant Soft Tissue Neoplasm+2 more
Roswell Park Cancer Institute 7
Large-scale testing (Phase 3)Study completedNCT00472459
What this trial is testing

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Who this might be right for
Actinic KeratosisWartsBasal Cell Carcinoma+2 more
Galderma R&D 82
Testing effectiveness (Phase 2)Ended earlyNCT00496223
What this trial is testing

A Phase I/II Study of Sunitinib and Dacarbazine

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Not applicableLooking for participantsNCT07422779
What this trial is testing

Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia

Who this might be right for
Metastatic MelanomaSkin Cancer
Institute of Oncology Ljubljana 100
Testing effectiveness (Phase 2)Ended earlyNCT02974803
What this trial is testing

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Who this might be right for
MelanomaBrain Metastases
Canadian Cancer Trials Group 6
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Next Page